Page 101 - Prostate News Today

Cancer spreads via circulating tumor cells (CTCs) that travel through the blood to other organs, and they are nearly impossible to track. Now, researchers at the Georgia Institute of Technology have found a detection method that could revolutionize cancer treatment by showing how cancers metastasize and what stage they are. This could lead to earlier and more targeted treatment, beginning with a simple blood test.

According to a recent study from the University of Kentucky Markey Cancer Center, the common steroid betamethasone may be utilised to lessen the negative effects of radiation therapy for prostate cancer.

A new study suggests that the common steroid betamethasone could be used to reduce unwanted side effects of radiation treatments for prostate cancer.

Muscat: The surgery team at Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC) has performed the first minimally invasive treatment for an enlarged prostate...

MARION, ILLINOIS (WSIL) -- August is National Wellness month, and local health officials are urging preventative care as way to stay on top of your health.

A new study offers the possibility of unmasking genetic mutations in an organ well before commonly-used screening techniques detect signs of cancer.

Understanding which cells give rise to which areas of cancer can improve our understanding of how a tumor has grown and developed, including how it has changed genetically, over time. This has been made possible using a new technique called spatial transcriptomics, which allows scientists to see what genetic changes take place without breaking up the tissue they're looking at.

It is a feat to compete in an Ironman 70.3 race, which includes swimming 1.2 miles, biking 56 miles and running 13.1 miles. One man will attempt it while battling stage 4 cancer.

It is a feat to compete in an Ironman 70.3, which includes swimming 1.2 miles, biking 56 miles and running 13.1 miles. Now, imagine attempting to accomplish that while battling stage 4 cancer.

Imperial researchers have built a new easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly.